Population-based trends in pediatric hemolytic uremic syndrome in California, 1994-1999: Substantial underreporting and public health implications

American Journal of Epidemiology

Volumn 155, Issue 10, 2002, Pages 941-948

  Cummings, Kate C ^a   Mohle Boetani, Janet C ^a   Werner, S Benson ^a   Vugia, Duc J ^a  

^a Division of Communicable Disease Control   (United States)

Author keywords

Child; Escherichia coli infections; Escherichia coli O157; Hemolytic uremic syndrome; Hospitalization; Public health

Indexed keywords

SHIGA TOXIN;

CHILD HEALTH; DISEASE PREVALENCE; HEALTH MONITORING; PUBLIC HEALTH;

ARTICLE; CHILD; ESCHERICHIA COLI; EXPOSURE; FATALITY; FEMALE; HEMOLYTIC UREMIC SYNDROME; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; UNITED STATES;

ADOLESCENT; CALIFORNIA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DATA COLLECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; MALE;

UNITED STATES;

EID: 0037092947     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/155.10.941     Document Type: Article

References (45)

1. Renal manifestations of systemic diseases
2. Thrombotic thrombocytopenic purpura - Hemolytic uremic syndrome: Diagnosis and management
3. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome
4. Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli
5. Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other Shiga toxin-producing E. coli
6. Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: Results of a Canadian collaborative study
7. Verocytotoxin-producing Escherichia coli infection in hemolytic uremic syndrome in part of western Europe
8. Humoral immune response to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects
9. The role of Escherichia coli O157 infections in the classical (enteropathic) haemolytic uraemic syndrome: Results of a central European, multicentre study
10. Hemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France
11. Enterohemorrhagic Escherichia coli (EHEC) in pediatric hemolyticuremic syndrome: A prospective study in Germany and Austria
12. The United States national prospective hemolytic uremic syndrome study: Microbiologic, serologic, clinical and epidemiologic findings
13. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections
14. Human infections with Shiga toxin-producing Escherichia coli other than serogroup O157 in Germany
15. Community outbreak of hemolytic uremic syndrome attributable to Escherichia coli O111:NM - South Australia, 1995
16. Communitywide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli
17. Prevalence of non-O157:H7 Shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska
18. A nationwide case-control study of the Escherichia coli O157:H7 infection in the United States
19. Hemolytic uremic syndrome
20. Screening for Escherichia coli O157:H7 - A nationwide survey of clinical laboratories
21. Escherichia coli O157:H7 diarrhea in the United States: Clinical and epidemiologic features
22. Escherichia coli O157:H7: Clinical, diagnostic and epidemiological aspects of human infection
23. Escherichia coli O157:H7 and the hemolytic uremic syndrome: Importance of early cultures in establishing the etiology
24. Results from 3 years of active surveillance for hemolytic uremic syndrome (HUS) through FoodNet, United States, 1997-1999
25. Hemolytic-uremic syndrome surveillance to monitor trends in infection with Escherichia coli 0157 and non-O157 enterohemorrhagic E. coli in Austria
26. Escherichia coli and the hemolytic-uremic syndrome
27. A population-based study of hemolytic-uremic syndrome in Oregon, 1979-1982
28. The increasing incidence of the hemolytic-uremic syndrome in King County, Washington: Lack of evidence for ascertainment bias
29. Hemolytic-uremic syndrome: A population-based study in Washington, DC, and Baltimore, Maryland
30. Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988
31. Haemolytic uraemic syndromes in the British Isles 1985-8: Association with verocytotoxin producing Escherichia coli. Part I: Clinical and epidemiologic aspects
32. Hemolytic uremic syndrome epidemiology: A population-based study in King County, Washington, 1971 to 1980
33. Transmission of Escherichia coli O157:H7 infection in Minnesota child day-care facilities
34. Surveillance for E. coli O157:H7 infections in FoodNet sites, 1996-1998: No decline in incidence and marked regional variation
35. Risk factors for sporadic infection with Escherichia coli O157:H7
36. Preliminary FoodNet data on the incidence of foodborne illnesses - Selected sites, United States, 2000
37. E. coli, antibiotics, and the hemolyticuremic syndrome
38. Toxin gene expression by Shiga toxin-producing Escherichia coli: The role of antibiotics and the bacterial SOS response
39. A comparison of three HUS surveillance methods in Oregon
40. Practice guidelines for the management of infectious diarrhea